MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.

Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, Dodick DW. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Headache. 2011 Apr; 51(4):507-17.

View in: PubMed